Table 2.

Acanthamoeba keratitis experimental therapies.

Experimental azole-based drug combinations	Reference
0.02% PHMB + 0.1% propamidine	[78]
0.02% chlorhexidine + 0.1% propamidine	[79]
200 mg ketoconazole + 0.2% chlorhexidine + ciprofloxacin + 1% atropine	[132]
Oral itraconazole + 0.1% topical miconazole + surgical debridement	[133]
0.1% miconazole + 150 mg oral itraconazole	[133]
0.02% chlorhexidine + 50 mg ketoconazole	[134]
1% voriconazole + 0.02% PHMB	[135]
Cryosurgery + 300 mg oral fluconazole	[52]
4 mg/mL topical posaconazole	[136]